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Abstract.  Caldesmon is present in a high molecular 
mass form in smooth muscle and predominantly in a 
low molecular mass form in nonmuscle cells. Their 
biochemical properties are very similar.  To examine 
whether these two forms of caldesmon behave differ- 
ently in cultured cells, we microinjected fluorescently 
labeled smooth muscle and nonmuscle caldesmons 
into fibroblasts. Simultaneous injection of both caldes- 
mons into the same cells has revealed that both high 
and low relative molecular mass caldesmons are 
quickly (within  10 min) and stably (over 3 d) incorpo- 
rated into the same structures of micr0filaments in- 
cluding stress fibers and membrane ruffles, suggesting 
that nonmuscle cells do not distinguish nonmuscle cal- 
desmon from smooth muscle caldesmon.  The effect 
of calmodulin on the incorporation of caldesmon has 
been examined by coinjection of caldesmon with 
calmodulin.  We have found that calmodulin retards the 
incorporation of caldesmon into stress fibers for a short 
period (10 min) but not for a longer incubation (30 
min).  The behavior of caldesmon in developing mus- 
cle cells was also examined because we previously ob- 
served that caldesmon disappears during myogenesis 
(Yamashiro,  S., R. Ishikawa,  and F. Matsumura.  1988. 
Protoplasma Suppl. 2:  9-21).  We have found that,  in 
contrast to its stable incorporation  into stress fibers of 
fibroblasts, caldesmon is unable to be incorporated 
into thin filament structure (I-band) of differentiated 
muscle. 
C 
ALDESMON, first  identified  in  smooth muscle,  is  a 
unique actin binding protein whose binding  to actin 
is regulated  by Ca2+/calmodulin (24).  A wide vari- 
ety of nonmuscle cells have been reported to contain caldes- 
mon, which shows lower molecular masses on SDS gels than 
does smooth muscle caldesmon  (ranging  from 70,000  to 
80,000 vs. 140,000 D of smooth muscle caldesmon) (3, 8, 16, 
29). In cultured cells,  nonmuscle caldesmons are found to 
be colocalized with actin,  suggesting  their involvement  in 
microfilament  organization  and the regulation  of cell motil- 
ity. Both muscle and  nonmuscle  ealdesmon  have  similar 
properties including  a rodlike molecular shape, heat stabil- 
ity, calmodulin regulation  of actin binding,  self-association 
through  disulfide  bonds,  periodic localization  along  actin 
filaments,  and stimulation  of actin binding  of tropomyosin 
(1-3, 8, 16, 24, 28, 29). Bryan et al. have recently revealed 
a structural difference  between these two types of chicken 
caldesmon through  eDNA cloning (4;  Bryan, J.,  R.  Lee, 
S. J. Chang,  and W.  G.  Lim.  1989. J.  Cell Biol. 109[No. 
4,  Pt.  2]:189a  [Abstr.]).  While NH2-terminal  (200 amino 
acids) and COOH-terminal (324 amino acids)  regions are 
exactly the same in smooth muscle and nonmuscle caldes- 
mons,  nonmuscle caldesmon is missing  232 amino acids 
from the central region of smooth muscle caldesmon, includ- 
ing a characteristic domain with an eightfold repeat of a 13 
amino acid sequence.  The sequence data together with the 
studies of domain mapping  by others (11, 15,  22, 25,  30) 
have  placed the actin-  and calmodulin-binding  domain at 
the COOH-terminal  end of the molecule and  the myosin 
binding  domain at the NH2 terminus.  These studies  have 
also revealed  that  caldesmons have much lower molecular 
masses than predicted by SDS-PAGE. The calculated molec- 
ular masses for chicken smooth muscle and nonmuscle cal- 
desmons are 87,000 and 60,000 D, respectively. 
The differences  in biological functions of these caldes- 
mons caused by the structural difference are not clear.  The 
wide occurrence of the nonmuscle type of caldesmon in non- 
muscle tissue and culture cells suggests that nonmuscle cal- 
desmon may function in a way different from smooth muscle 
caldesmon.  In this  study,  we have  microinjected fluores- 
cently  labeled  muscle  and  nonmuscle  caldesmons  into 
fibroblasts in order to see whether these two types of caldes- 
mons behave differently  in vivo.  We have found that both 
high and low relative molecular mass caldesmons are incor- 
porated into the same structures of microfilaments  despite 
the structural  difference. In addition,  because we previously 
observed that caldesmon disappears during myogenesis (28), 
we have examined whether caldesmon is stably incorporated 
into actin structures of muscle cells. We have observed that, 
unlike fibroblasts,  muscle cells actively exclude caldesmon 
from thin filament  structure. 
Materials and Methods 
Protein Purification 
Smooth muscle caldesmon was  purified from  frozen bovine aorta  and 
chicken gizzard by the method of Bretscher (1) with slight modification as 
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by the method described previously (28) except that the last hydxoxylapatite 
column was omitted. COOH-terminal 40-kD fragments of chick gizzard 
smooth muscle caldesmon were prepared according to Fujii et al.  (11). 
Skeletal  muscle actin was purified as described previously (18).  Alpha- 
actinin was purified from chicken gizzard  as described by Feramisco and 
Burridge (9), and conjugated with FITC as described (23). 
Conjugation of Caidesmon with Fluorescent Dyes 
Caldesmons from smooth muscle and nonmuscle cells were conjugated with 
tetramethylrhodamine-5-(and-6)-iodoacetamide (TMRIA)  1 or 5-iodoacet- 
amidofluorescein  OAF)  (Molecular Probes Inc.,  Eugene,  OR).  Caldes- 
mons are known to form oligomers through disulfide bonds when reducing 
agents  are removed by dialysis.  Because this will eliminate free cysteine 
residues from caldesmon for conjugation with the dyes, we have conjugated 
caldesmons with excess  amounts of the dyes over the concentration of 
reducing agents present in caldesmon preparation. In fact we found that cal- 
desmun was conjugated  very poorly with the dyes when reducing agents 
were removed by dialysis. 
Caldesmons (1-5 mg/ml) in 20 mM Tris-acetate buffer containing 0.1 M 
KC1 and 0.2 mM DTT were incubated with 0.5-1  mM of either TMRIA 
or IAF on ice for 4  h.  The reaction was  terminated by the addition of 
2-mereaptoethanol to a final concentration of 50 raM. The free dye was re- 
moved by using Bio-Beads  SM-2 (Bio-Rad Laboratories, Richmond, CA) 
as described (19). For purification of caldesmon with actin binding ability, 
dye-conjugated  caldesmon (final concentration, 0.5 mg/mi) was incubated 
at room temperature for 1 h with 1 mg/ml of actin in 20 mM imidazole 
buffer ofpH 7.0 containing 0.1 M KC1 and 1 mM DTT. After centrifugation 
with an Alrfuge (26 psi x  20 min; Beckman Instruments, Inc., Palo Alto, 
CA), the pellets were suspended  in 50 ~  of 20 mM potassium phosphate 
or 20 mM imidazole buffer of pH 7.0 containing 0.1 M KC1 and 1 mM DTT. 
After heat treatment at 100°C  for 10 rain, dye-conjugated  caldesmons (1 
mg/mi) were recovered in the supernatants by centrifugation with an Air- 
fuge, and used for microinjection or actin binding assay. 
The dye/protein ratios of TMRIA-conjugated  caldesmons were estimated 
based on a molar extinction coefficient of 47,000 at 552 nm (7), and assum- 
ing that molecular masses of nonmuscle and smooth muscle caldesmon 
were 60,000 and 87,000 D, respectively  (4; Bryan, J., R. Lee, S. J. Chang, 
and W. G. Lira.  1989. J.  Cell Biol. 109[No.  6, Pt. 2]:189a[Abstr.]). 
Cell Culture 
REP-52 cells (an established rat embryo cell line) and gerbil fibroma cells 
(CCL-146; American Type Culture Collection, Rockville, MD) were main- 
tained in DME containing 10% newborn calf serum in an atmosphere of 
5 % CO2 and 95 % air at 37°C.  Chick embryo myoblasts  were prepared 
from the thigh muscle of an ll-d chick and cultured in DME supplemented 
with 15% horse serum and 2% of chick embryo extracts.  They began to 
fuse at 2 d and differentiated  into myotubes with sarcomere structures at 
,'~10 d.  Chick embr3~ fibroblasts  were  also maintained in DME  sup- 
plemented with 15% horse serum and 2% of chick embryo extracts. 
Microinjection 
The technique of Graessmann and Graessmann (12) was used for microin- 
jection of the fluorescently  labeled proteins into cells.  Needles were made 
with a Narishige needle puller and injection was performed with a Narishige 
micromanipuiator (Narishige,  Tokyo, Japan) attached to an Olympus in- 
1.  Abbreviations used  in  this paper:  IAF,  5-iodoacetamidofluorescein; 
TMRIA, tetramethylrhodamine-5-(and-6)-iodoacetamide. 
verted microscope (IMT-2). After injection, cells were incubated in an CO2 
incubator, fixed at a certain time (usually at 1611) with 3.7% formaldehyde 
in PBS, washed with PBS, and mounted on slides with gelvatol.  Fluores- 
cence was  observed with an Olympus BH-2  microscope equipped  for 
epifluorescence  and phase contrast. Fluorescent photographs were taken 
using Kodak T-Max P3200 films and developed with T-Max developer for 
an ASA rating of 3,200. Phase-contrast photographs were taken with Kodak 
Technical Pan films and developed with Rodinal developer. When the incor- 
poration of fluorescent  caldesmon in living cells was examined,  or when 
fluorescence was at a low level, images were taken with a SIT video camera 
(Dage-MTI,  Inc.), processed with an Argus 10 image processor (Photo- 
tonic, Hamamatsu City, Japan), and subsequently photographed from the 
monitor with 35 mm Technical Pan film (developed with Technidol liquid 
developer). 
Binding of Dye-conjugated Caidesmon on 
Permeabilized Cell Models 
REF-52 cells were treated on ice for 90 s with 0.03 % Triton X-100 contain- 
ing 0.1 M Pipes,  5 mM MgCI2,  1 mM EGTA.  After gentle washing with 
PBS containing 5 mM MgCI2, permeabilized cells were incubated at 37°C 
for 15 rain with fluorescently labeled caddesmons (0.3-0.5 mg/ml) in 20 mM 
imidazole buffer ofpH 7.0, 0.1 M KCI, and 1 mM DTT, then washed gently 
with PBS containing 5 raM MgCI2, fixed with 3.7% formaldehyde in PBS, 
and observed by an epifluorescent microscope.  In some experiments, 0.4 
mg/ml of calmodulin with either 0.2 mM CaC12 or  1 mM EGTA were 
added to fluorescently  labeled caldesmons to see effects of Ca2+/calmodu  - 
lin on the binding of caldesmon to cell models. 
Other Procedures 
Immunoduorescence was performed as described (27). Protein concentra- 
tions were determined by the BCA protein assay reagent (Pierce Chemical 
Co., Rockford, IL) using bovine serum albumin as a standard. Protein con- 
centrations of dye-conjugated caldesmons were determined as follows. Dye- 
conjugated caldesmon, together with intact ealdesmons with known con- 
centrations were  run on  SDS  gels,  stained with Coomassie blue,  and 
quantified  by densitometry as described (26).  SDS-PAGE was performed 
as described (29). Actin binding activity of caldesmon was assayed as de- 
scribed before (29). 
Results 
Actin Binding Properties of Dye-conjugated Smooth 
Muscle and Nonmuscle Caldesmons 
For the conjugation of smooth muscle and nonmuscle caldes- 
mons, we initially  tested two kinds of fluorescent dyes that 
are  different  in  the  reactivities.  One  is  iodoacetamides, 
which reacts with cysteine  residues of protein.  The other is 
isothiocyanates,  which  reacts  with  e-amino  residues.  Al- 
though caldesmons  conjugated  with  either  dye  were  ob- 
served to be incorporated  into stress fibers when injected, 
caldesmon conjugated  with  the latter  dyes  showed much 
higher background and more diffuse staining  than did cal- 
desmon conjugated with the former dyes. We have thus cho- 
sen fluorescein or rhodamine iodoacetamide for this study. 
Dye-conjugated  caldesmons were further purified by using 
Figure 1. Actin binding of TMRIA-conjugated smooth muscle (.4) and TMRIA-conjugated nonmuscle (B) caldesmons. Actin (0.5 mg/ml) 
was incubated for 1 h at room temperature with either 0.2 rag/rid of bovine aorta caldesmon (A) or 0.1 mg/ml of bovine liver caldesmon 
(B) in 20 mM imidazole buffer, 0.1 M  KCI, and 0.5 mM DTT in the presence or absence of calmodulin (0.4 mg/ml). After centrifugation 
with an Airfuge (28 psi  ×  20 min), both supernatants and pellets are suspended in equal amounts of SDS sample buffer and analyzed 
by SDS-PAGE.  Lane 1,  molecular weight markers (from top to bottom,  200000,  116,000,  97,000, 66,000, 43,000,  31D00, 21,000,  and 
14,000);  lanes 2-7,  actin binding of unconjugated caldesmon control; lanes 8-13 and a-f,  actin binding of dye-conjugated caldesmon; 
lanes 1-13,  Coomassie blue staining; lanes a-f, the same gel as in lanes 8-13 photographed with ultraviolet light. Lanes 3, 5,  7, 9,  11, 
13, b, d, and fare pellets; lanes 2, 4, 6, 8, 10, 12, a, c, and e are supernatants. Lanes 2, 3, 8, 9, a, and b, are in the presence of calmodulin 
and 0.1  mM CaCI2; lanes 4, 5, I0, ]1,  c and d, are in the presence of calmodulin and 1 mM EGTA; lanes 5, 6, 12, 13, e, and f, are in 
the absence of both calmodulin and CaCI2. 
The Journal of Cell Biology, Volume 111, 1990  2488 Yamakita et al. Microinjection of Caldesmon  2489 Figure 2. Binding of TMRIA-conjugated bovine liver caldesmon to cell models (REF-52 cells permeabilized with Triton X-100). (A) 
In the absence of calmodulin; (B) in the presence of Ca2+/calmodulin. 
F-actin binding ability of caldesmon as described ill Mate- 
rials and Methods. The molar ratios of dye (TMRIA) to the 
caldesmons were estimated as 0.75 for bovine aorta smooth 
muscle caldesmon, 0.5 for chicken gizzard caldesmon, and 
0.35 for bovine liver nonmuscle caldesmon. 
We have examined actin binding  properties  of purified 
dye-conjngated bovine smooth muscle and nonmuscle cal- 
desmons. As Fig.  1, A and B show, dye-conjugated caldes- 
mons appear to show actin binding ability similar to that 
of intact proteins. Furthermore,  actin binding of dye-conju- 
gated smooth muscle and nonmuscle caldesmon is regulated 
by Ca  2÷/calmodulin in the same way as that of intact mole- 
cule. Chick gizzard caldesmon labeled with the same dye 
also shows actin binding properties similar to those of intact 
proteins (data not shown). 
To further examine the actin  binding  property  of dye- 
conjugated caldesmons, we have examined their binding to 
a  permeabilized  cell  model with  or without  calmodulin. 
When calmodulin  is absent,  TMRIA-conjugated liver cal- 
desmons bind to stress fibers either in the presence or ab- 
sence of Ca  2+ (Fig. 2 A). When calmodulin is present,  the 
binding is regulated by Ca  2+/calnlOduiin as is the binding of 
dye-conjugated caldesmons to actin (Fig. 1). In the presence 
of Ca  2÷, caldesmon shows very weak binding to stress fibers 
(Fig. 2 B), while caldesmon binds well to a cell model in 
the absence  of Ca  2+.  Similar  results  were  obtained  with 
dye-conjugated smooth muscle caldesmon (data not shown). 
Microinjection of  Nonmuscle and Smooth Muscle 
Caldesmons into Fibroblasts 
We then microinjected  them into rat fibroblasts (REF 52 
cells) to see their incorporation into the microfilament struc- 
tures. As Fig. 3 shows, both bovine muscle and nonmuscle 
caldesmons are incorporated  into stress fibers periodically 
(,4 and C). These patterns of the incorporation correspond 
to the localization of  endogenous caldesmon revealed by im- 
munofluorescence (Fig. 3 G). 
The injected caldesmons,  regardless whether they come 
from nonmuscle or smooth muscle cells, are quickly and sta- 
bly incorporated  into stress fiber structures.  These caldes- 
mons are observed in stress fibers within 10 min after injec- 
tion and are stably present for over 3 d although the intensity 
of fluorescence is decreased by dilution due to cell division. 
We have also examined incorporation  of caldesmon into 
membrane ruffles because caldesmon is known to be local- 
ized  in membrane  ruffles as well.  To this end,  we have 
microinjected  caldesmon  into  chick  embryo  fibroblasts, 
which have more membrane ruffle structures than REF 52 
cells. As Fig. 3, E and F show, both bovine smooth muscle 
Figure 3. Distribution of dye-conjugated caldesmon in REF-52 cells (A-D) or in chick embryo fibroblasts  (E and F). Injection was per- 
formed with 1 mg/ml of TMRIA-conjugated bovine aorta caldesmon (A, K  and E), or I mg/ml of TMRIA-conjugated bovine liver caldes- 
mon (C, D, and F). Arrows show incorporation of caldesmon into membrane fumes. (G and H) Immunofluorescence of REF-52 cells 
stained with anti-caldesmon monoclonal antibody (SM12).  (A, C, E, F, and G) Fluorescent images; (B, D, and H) phase-contrast images. 
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ruffles as  well  as  stress  fibers.  Similar incorporation to 
microfilament structures is also seen with injection of dye- 
conjugated chick gizzard caldesmon (data not shown). 
We have observed distribution of injected caldesmon in 
living cells because Cooper et al. (6) have shown that fixation 
changes  the  distribution  of  microinjected  gelsolin  from 
diffuse to fibrillar patterns. As Fig. 4 shows, injected caldes- 
mon was observed to be incorporated into stress fibers of  liv- 
ing REF 52 cells (Fig. 4 A), as well as membrane ruffles of 
living gerbil fibroma cells (Fig. 4 B).  Although the back- 
ground is somewhat higher than that of fixed images, the in- 
corporation of  caldesmon in living cells appears very similar 
to the pattern of distribution shown by fixed cells. 
Simultaneous Injection of  Smooth and Nonmuscle 
Caldesmons into the Same Cells 
Because the incorporation of smooth muscle caldesmon ap- 
pears to be similar to that of  nonmuscle caldesmon, we asked 
whether these two types of  caldesmons are incorporated into 
the same structures of microfilaments. To distinguish smooth 
and nonmuscle caldesmon in the same cells, these two cal- 
desmons were  separately labeled with two different dyes 
(TMRIA and IAF), mixed to make a equal molar concentra- 
tion (6/zM of smooth muscle and 6/zM of  nonmuscle caldes- 
mon), and injected into REF 52 or gerbil fibroma cells. As 
Fig. 5, A, B, and C show, coinjected smooth muscle aao non- 
muscle  caldesmons  show  indistinguishable  incorporation 
into stress fibers in the same REF 52 cells. The injection into 
gerbil fibroma cells (Fig. 5, D, E, and F) has clearly demon- 
strated that two species of caldesmon are equally distributed 
into two different microfilament structures, i.e., stress fibers 
and membrane ruffles. The fluorescent structures derived 
from smooth muscle caldesmon are found to correspond ex- 
actly to those derived from nonmuscle caldesmon. 
To examine whether these two species of caldesmon com- 
pete each other in the incorporation into stress fibers, we 
microinjected 5 ~M (final concentration) of dye-conjugated 
bovine liver or chick smooth muscle caldesmon that had 
been mixed with varying concentrations (0-80 ~M) of  either 
smooth muscle or liver unconjugated caldesmon. If, for ex- 
ample, smooth muscle caldesmon bind to stress fibers better 
than nonmuscle species,  smooth muscle unconjugated cal- 
desmon would compete fluorescent nonmnscle caldesmon 
out of stress fibers more effectively  than nonmuscle unconju- 
gated caldesmon does. We have found, however,  that both 
species of caldesmon give the same effects; fluorescently 
conjugated liver  caldesmon on  stress  fibers  was  equally 
diluted out as the concentrations of unconjugated caldes- 
Figure  4.  Distribution  of TMRIA-con- 
jugated caldesmon (1 mg/ml) in living 
REF-52 cells  (A)  and  gerbil  fibroma 
cells (B). The incorporation into stress 
fibers (A) and into membrane ruffles (B, 
arrows) is similar to those observed in 
fixed cells (Figs.  3  and 5). 
The Journal of Cell Biology, Volume 111, 1990  2492 Figure 5. Simultaneous injection of smooth muscle and nonmuscle caldesmon into the same cells. REF-52 cells (A-C) or gerbil fibroma 
cells (D-F) were injected with a mixture of TMRIA-conjugeted  bovine aorta caldesmon (B and E) and IAF-conjugated  bovine liver caldes- 
mort (C and F). (A and D) Phase contrast; (B,  C, E, and F) fluorescent image. Arrows show membrane ruffles. Note that two species 
of caldesmon are incorporated into the same structures of microfilaments. Injection with a mixture of IAF-conjugated smooth muscle and 
TMRIA-conjugated nonmuscle caldesmons gave similar results. 
Yamakita ctal. Microinjecffon of Caldesmon  2493 Figure 6. Smooth muscle and nonmuscle caldesmons do not compete each other in the incorporation into stress fibers. TMRIA-conjugated 
bovine liver caldesmon (final concentration, 5 ~tM) was first mixed with buffer alone (A), or varying concentrations of unconjugated smooth 
muscle (B, 40/tM; D, 80/zM) or nonmuscle (C, 40/zM; E, 80/zM) caldesmon, and injected into REF-52 cells. Fluorescent images were 
taken with a SIT video camera as described in Materials and Methods. Note that both species of caldesmon equally decrease the fluores- 
cence of bovine liver caldesmon incorporated into stress fibers, suggesting that cells do not distinguish between these two species of cal- 
desmon. 
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chymotryptic fragments (0.3 mg/ml) into REF- 
52 cells. 
mon,  regardless of species of caldesmon, were increased 
(Fig. 6). These results suggest that nonmuscle and smooth 
muscle caldesmons appear to have an indistinguishable abil- 
ity of the incorporation into stress fibers. 
Injection of COOH-Terminal Fragments 
into Fibroblasts 
Because both high and low relative molecular mass caldes- 
mons are  incorporated into the same  structures of stress 
fibers despite the structural differences, we asked whether 
even small fragments of caldesmon with the functional actin 
binding domain are incorporated into stress fibers. Studies 
on domain structure of gizzard caldesmon have revealed that 
the actin binding and calmodulin  binding domain is localized 
in COOH-terminal 40-kD fragments (11, 15,  22, 25,  30). 
The protein sequence derived from eDNA cloning has re- 
vealed that one of the two cysteine residues of chick gizzard 
caldesmon are localized in the middle of  the COOH-terminal 
fragments, allowing us to conjugate COOH-terminal frag- 
ments with TMRIA to see their incorporation. Dye-conju- 
gated COOH-terminal fragments was also purified by co- 
sedimentation with F-actin and injected into REF-52 cells. 
As Fig. 7  shows,  COOH-terminal fragments are incorpo- 
rated into stress fibers. Their incorporation in some places 
appears periodic as seen in the case of the injection of intact 
molecule. 
Effects of Coinjection with Calmodulin 
Effects of coinjection of caldesmon with Ca2+/calmodulin 
have been examined because actin binding of caidesmon is 
inhibited by Ca2+/calmodulin  in vitro. To ensure the com- 
plex formation, dye-conjugated caldesmon (1 mg/ml) is in- 
cubated with 20 times molar excess (final concentration, 4 
mg/ml) of calmodulin over caldesmon in the presence of 0.1 
mM of CaCl:~and then injected into fibroblasts. As a con- 
trol,  caldesmon in 0.1  mM CaC12 but without calmodulin 
was injected.  As  Fig.  8, A  and B  show,  coinjection with 
calmodulin retards  the incorporation of caldesmon for a 
short time after injection. While control caldesmon without 
calmodulin (Fig.  8 B)  is quickly incorporated into stress 
fibers within 10 min, most of caldesmon complexed with 
calmodulin (A) is diffusely present at the same time. The 
effect of calmodulin, however, disappears as the cells are in- 
cubated for longer than 30 rain. AS Fig. 8,  C and D  show, 
the incorporation of caldesmon coinjected with calmodulin 
(C) appears indistinguishable from that (D) of control. 
Microinjection of Dye-conjugated Caldesmon into 
Muscle Cells 
Our results indicate that caldesmon is a stable protein that 
remains bound to stress fibers over 3 d. On the other hand, 
we previously observed that nonmuscle caldesmon present 
in  myoblasts disappears  during  fusion  of myoblasts into 
myotubes (28).  We  have thus  examined whether  smooth 
muscle or nonmuscle caldesmon is stably incorporated into 
actin microfilaments of developing muscle cells. Chick myo- 
blasts were used for this purpose because these cells are eas- 
ily differentiated into myotubes with sarcomere structures. 
AS Fig. 9, A and B show, caldesmon is unexpectedly found 
in A-bands but not in I-bands when it is injected into myo- 
tubes with sarcomere structures. This A-band incorporation 
(Fig. 9  C) is quite unstable and quickly disappears after a 
16-h incubation (Fig. 9 E). As a control, we have coinjected 
FITC-labeled tx-actinin  into myotubes. As Fig. 9, D  and F 
show, ~actinin remains stably incorporated into Z-bands af- 
ter 16 h. Similar results were obtained with the injection of 
smooth muscle caldesmon. 
We have also injected caldesmon into myotubes that have 
Yamakita et al. Microinjection of Caldesmon  2495 Figure 8. Effects of coinjection with calmodulin on the incorporation of caldesmon. A and C are fluorescent images at 10 and 30 rain, 
respectively, after coinjection of TMRtA-conjugated caldesmon with calmodulin in the presence of 0.1 mM CaC12. B and D are fluores- 
cent images at 10 and 30 rain, respectively, after injection with TMRIA-conjugated caldesmon in 0.1 mM CaCI2 without calmodulin. 
not  developed sarcomere  structures.  While  caldesmon  is 
found to be incorporated into microfilament bundles of myo- 
tubeS,  the incorporation is again very unstable and disap- 
pears after a 16-h incubation (data not shown). These results 
suggest that, unlike fibroblasts, muscle cells actively exclude 
caldesmon from their actomyosin system. 
Discussion 
Nonmuscle Cells Do Not Distinguish Smooth Muscle 
and Nonmuscle Caldesmons 
Smooth muscle caldesmon has additional central regions (27 
kD) including a repeated domain while both nonmuscle and 
smooth  muscle  share  NH2-terminal  and  COOH-terminal 
portions (4; Bryan, J., R. lee, S. J. Chang, and W. G. Lira. 
1989.  ,/.  Cell Biol. 109[No.  4,  Pt.  2]:189a[Abstr.]).  Our 
results indicate that the central domain does not inhibit the 
incorporation of caldesmon into actin structures of nonmus- 
cle cells. Both smooth muscle and nonmuscle caldesmons 
are quickly and stably incorporated into stress fibers as well 
as membrane ruffles (Fig.  5).  The incorporation is appar- 
entiy normal because it is indistinguishable from the local- 
ization of endogenous caldesmon (Fig. 3). Furthermore, one 
species of caldesmon does not appear to compete the other 
out from stress fibers (Fig.  6).  These results indicate that 
nonmuscle cells do not distinguish smooth muscle and non- 
muscle  caldesmons  in  terms  of  the  incorporation  into 
microfilaments. This notion is extended by the observation 
that a 40-kD actin and calmodulin binding proteolytic frag- 
ment is incorporated into stress fibers (Fig. 7), suggesting 
that caldesmon incorporation needs only the actin-binding 
domain. 
The introduction of smooth muscle caldesmon at a con- 
centration comparable to the endogenous nonmuscle caldes- 
mon  does  not  appear  to  affect  the  organization  of  the 
microfilament system in fibroblasts. The highest concentra- 
tion of smooth muscle caldesmon used for microinjection 
was 7 mg/ml.  Microinjection usually introduces ,~,10  -t3 li- 
ter of solution into most fibroblasts (10), which allows for 
the introduction of 4  ×  10~ molecules per cell.  Because 
,~,0.03-0.08 % of  the cellular protein is nonmuscle caldesmon 
(Ishikawa,  R.,  and  F.  Matsumura,  unpublished  results), 
each cell contains '~2-6  ×  l06 molecules of caldesmon per 
The Journal of Cell Biology,  Volume 111, 1990  2496 Figure  9.  Injection of TMRIA-conjugated bovine liver caldesmon (1.0 mg/ml) into chick myotubes. (A) Phase contrast; (B) fluorescent 
image. Arrowheads indicate A-bands. In C-F, FITC-conjugated ot-actinin (2 mg/ml) was coinjected as a control. (C and D) 2 h after injec- 
tion; (E and F) 16 h after injection; (C and E) fluorescent images of TMRIA-conjugated caldesmon; (D and F) images of FITC-conjugated 
o~-actinin. 
cell assuming that a fibroblast contains ~1 ng of  protein. The 
injected smooth muscle caldesmon thus roughly corresponds 
to the concentration of the endogenous caldesmon, but the 
injected caldesmon does not have any observable effects on 
the organization of microfilaments. 
The incorporation of caldesmon into developing muscle 
cells is very different from its incorporation into fibroblasts. 
When caldesmon is injected into myotubes with sarcomere 
structures, it is unexpectedly incorporated into the A-band, 
rather than the I-band, just for a short time. On overnight in- 
cubation,  caldesmon is excluded from muscle cells.  This 
A-band incorporation is probably due to the direct binding 
of caldesmon to myosin (13, 14). These results are consistent 
with our previous  observation that caldesmon disappears 
during fusion of myoblasts into myotubes but inconsistent 
with the report describing the presence of  caldesmon in mus- 
cle cells (21).  Further, these results suggest that thin fila- 
ments of  developing muscle cells have some structure that in- 
hibits the binding of caldesmon. At present, we do not know 
what inhibits the acfin bindifig of caldesmon. One candidate 
for  such  structure  may be  troponin/tropomyosin system. 
However, we could not observe competitive inhibition of ac- 
tin binding of caldesmon by tropomyosin/troponin in vitro 
(data not shown). 
Effects of the Modification of  Cysteine Residues 
on the Actin Binding 
The modification  of  thiol residues of chicken smooth muscle 
caldesmon or its 40-kD chymotryptic fragments with either 
fluorescein or rhodamin iodoacetamides does not appear 
to alter actin-binding properties of these proteins,  nor to 
Yamakita ¢t al.  Microinjection of Caldesmon  2497 change regulation of their actin binding by Ca2+/calmodu  - 
lin. This is consistent with the domain structure of the 40-kD 
fragments.  According  to the domain mapping studies  (4, 
22), a cysteine residue is located appro  "xnnately at the middle 
of the 40-kD fragments, and COOH-terminal 25-kD frag- 
ments generated by chemical cleavage at the cysteine residue 
still retain actin and calmodulin binding properties. 
EHects of Calmodulin 
The coinjection of Ca  2+/calmodulin with caldesmon inhibits 
initial incorporation of caldesmon for 10 rain. This retarda- 
tion may represent the time period for the dissociation  of 
a  ternary complex  of  Ca2+/calmodulin/caldesmon inside 
cells. The level of endogenous calmodulin in CHO cells is 
reported as  150 ng/106 cells (20).  Assuming  that REF 52 
cells  have the  same  level  of calmodulin,  the  amount of 
calmodulin injected would be three to six times higher than 
the concentration of endogenous calmodulin,  and this level 
of calmoduiin would be high enough for the dissociation of 
both endogenous and exogenous caldesmons from actin fila- 
ments if calcium is present. This estimation may thus sug- 
gest that calcium concentration inside cells may be quickly 
dropped below the micromolar level. Other possibilities  for 
this  short-term effect  by  calmodulin  are  that calmoduiin 
may be consumed for other cellular functions, or calmodulin 
may not function in the dissociation  of caldesmon in vivo. 
Lehman,  for  example,  questioned  the  regulatory  role of 
calmodulin for the dissociation of caldesmon because he has 
observed that content of smooth muscle caldesmon  is not 
changed when native thin filaments are prepared in either 
Ca2÷-free or Ca2÷-contalning medium in the presence of en- 
dogenous calmodulin (17). Further studies are needed for the 
elucidation of the biological significance of calmodulin regu- 
lation of actin-caldesmon  interactions. 
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